Home / Learn / Resource Detail

Supporting Skin Health in Patients with Breast Cancer

March 20, 2025

Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!

 

Dermatologic toxicities associated with oncology treatment can significantly impact quality of life and treatment adherence for patients with breast cancer. The Association of Cancer Care Centers (ACCC) is committed to providing up-to-date guidance on managing these dermatologic side effects to enhance clinical outcomes. In this episode of CANCER BUZZ, Allison Gordon, MD, a supportive oncodermatologist at Memorial Sloan Kettering Cancer Center, discusses the dermatologic toxicities associated with breast cancer treatment. Dr Gordon explores preventive measures that oncologists can implement early in the treatment course and offers alternative resources for oncology clinicians when an oncodermatologist referral is not feasible. Additionally, she highlights capivasertib, a recently approved antineoplastic drug, and reviews its associated cutaneous adverse events, along with supportive care and management strategies.

 

Thank you to AstraZeneca for their support of this program.

 

 

Guests:

/images/podcast/gordon-allison-circle.png

Allison Gordon, MD

Dermatologist

Memorial Sloan Kettering Cancer Center

New York, NY  

“Because many of these medications can cause dry skin, which can be debilitating for patients... [we recommend] using a thick ointment or cream moisturizer on their damp skin after they shower... it doesn't have to be anything expensive... I always recommend that to all patients regardless of what treatment they're on.”– Allison Gordon, MD

 

Additional Reading/Sources:

          The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.